Back to Report Store Home

Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 – Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

  • Published: Dec-2018
  • Report Code: GBIHC487MR
  • Report Format: pdf

Description

List of Tables

Table 1: NAFLD Definitions and Phenotypes 10

Table 2: Major Symptoms of NASH 11

Table 3: Etiologies of NASH 12

Table 4: Histopathological Abnormalities in NASH 17

Table 5 NAFLD Activity Score and Staging System 20

Table 6: Therapeutic Management in NASH 24

Table 7: NASH Therapeutics Market, Global, Licensing Deals Valued $100m and Above, 2007–2018 86

Table 8: NASH Therapeutics Market, Global, Co-development Deals with Deal Value 10 and above, 2007–2018 92

Table 9: NASH Therapeutics Market, Global, All Pipeline Products, Discovery, 2018 93

Table 10: NASH Therapeutics Market, Global, All Pipeline Products, Preclinical, 2018 95

Table 11: NASH Therapeutics Market, Global, All Pipeline Products, IND/CTA-filed, 2018 98

Table 12: NASH Therapeutics Market, Global, All Pipeline Products, Phase I, 2018 99

Table 13: NASH Therapeutics Market, Global, All Pipeline Products, Phase II, 2018 100

Table 14: NASH Therapeutics Market, Global, All Pipeline Products, Phase III, 2018 101

Table 15: NASH Therapeutics Market, APAC, Market Forecast, 2017–2024 101

Table 16: NASH Therapeutics Market, India, Market Forecast, 2017–2024 102

Table 17: NASH Therapeutics Market, China, Market Forecast, 2017–2024 102

Table 18: NASH Therapeutics Market, Australia, Market Forecast, 2017–2024 103

Table 19: NASH Therapeutics Market, South Korea, Market Forecast, 2017–2024 103

Table 20: NASH Therapeutics Market, Japan, Market Forecast, 2017–2024 104

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards